계명대학교 의학도서관 Repository

Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up

Metadata Downloads
Author(s)
김천일정원호하지용김병훈박철희
Alternative Author(s)
Jung, Won HoPark, Choal HeeKim, Chun IlKim, Byung HoonHa, Ji Yong
Publication Year
2017
Keyword
Needle biopsyProstate-specific antigenProstatic neoplasmsWatchful waiting
Abstract
Purpose: Update and reanalysis of our experience of active surveillance (AS) for prostate cancer (PCa) in Korea.
Materials and Methods: A prospective, single-arm, cohort study was initiated in January 2008. Patients were selected according
to the following criteria: Gleason sum ≤6 with single positive core with ≤30% core involvement, clinical stage≤T1c, prostate-specific
antigen (PSA)≤10 ng/mL, and negative magnetic resonance imaging (MRI) results. Follow-up was by PSA measurement every
6 months, prostate biopsies at 1 year and then every 2–3 years, and MRI every year.
Results: A total of 80 patients were treated with AS. Median follow-up was 52 months (range, 6–96 months). Of them, 39 patients
(48.8%) discontinued AS for various reasons (17, disease progression; 9, patient preference; 10, watchful waiting due to old age; 3,
follow-up loss; 2, death). The probability of progression was 14.0% and 42.9% at 1 and 3 years, respectively. Overall survival was
97.5%. PCa-specific survival was 100%. Progression occurred in 5 of 7 patients (71.4%) with a prostate volume less than 30 mL, 7 of
40 patients (17.5%) with a prostate volume of 30 to 50 mL, and 5 of 33 patients (15.2%) with a prostate volume of 50 mL or larger.
There were 8 detectable positive lesions on follow-up MRI. Of them, 6 patients (75%) had actual progressed disease.
Conclusions: Small prostate volume was associated with a tendency for cancer progression. MRI was helpful and promising for
managing AS. Nevertheless, regular biopsies should be performed. AS is a safe and feasible treatment option for very-low-risk PCa
in Korea. However, AS should continue to be used in carefully selected patients.
Department
Dept. of Urology (비뇨의학)
Publisher
School of Medicine
Citation
Invastigative and Clinical Urology, Vol.58(3) : 164-170, 2017
Type
Article
ISSN
2466-0493
DOI
10.4111/icu.2017.58.3.164
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/33382
Authorize & License
  • AuthorizeOpen
Files in This Item:

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.